EXHIBIT BPurchase Agreement • March 9th, 2001 • Oxford Bioscience Partners Iii Lp • Electromedical & electrotherapeutic apparatus • Delaware
This Purchase Agreement (the "Agreement") is made as of October 17, 2000 (the "Agreement Date"), by and between Criticare Systems, Inc., a Delaware corporation (the "Company") with its principal office at 20925 Crossroads Circle, Wankesha, WI 53186, and the purchasers set forth on Exhibit A hereto (individually a "Purchaser" and collectively the "Purchasers").
EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed...Joint Filing Agreement • October 27th, 2000 • Oxford Bioscience Partners Iii Lp • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Criticare Systems, Inc. or any subsequent acquisitions or dispositions of equity securities of Criticare Systems, Inc. by any of the undersigned.
JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their...Joint Filing Agreement • March 9th, 2001 • Oxford Bioscience Partners Iii Lp • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Criticare Systems, Inc. or any subsequent acquisitions or dispositions of equity securities of Criticare Systems, Inc. by any of the undersigned.
